Our results showed a decrease in cell migration at 12- and 24-h time points (Fig. 3B), proliferation (Fig. 3C), and invasion (Fig. 3D) in cells treated with inhibitor as compared to control cells there was little decrease in proliferation and invasion but no significant change in migration in p32 shRNA cells after Akt inhibitor LY294002 treatment suggesting p32-dependent Akt activation mainly leads these functions in melanoma. Here, AKT1 is linked to melanoma.